Medications Affecting the Insulin-Like Growth Factor 1/Growth Hormone Axis, Including Teprotumumab, Somatostatin Analogs, and Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies, Are Associated With Elevated Reporting Odds of Alopecia in Women: A Pharmacovigilance Study

    August 2023 in “ Journal of The American Academy of Dermatology ”
    Patrick Jedlowski, Mahdieh F. Jedlowski, Mohammad Reza Fazel
    Image of study
    TLDR Some drugs linked to growth hormones may increase the chance of hair loss in women.

    We don't know much about this study yet.

    We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.
    Discuss this study in the Community →

    Cited in this study

    3 / 3 results